Read about the latest insights in skin cancer care with a new whitepaper on advanced basal cell carcinoma and advanced cutaneous squamous cell carcinoma. View the complimentary resource today!
At the start of the second day of Fall Dermatology Week 2023, Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP, and Linda Stein Gold, MD, presented their session, “The Dermatology Team."
At the start of the second day of Fall Dermatology Week 2023, Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP, and Linda Stein Gold, MD, presented their session, “The Dermatology Team."
The US Food and Drug Administration recently announced approval of bimekizumab-bkzx for the treatment of adults with moderate to severe plaque psoriasis.
The US Food and Drug Administration recently announced approval of bimekizumab-bkzx for the treatment of adults with moderate to severe plaque psoriasis.
Prior to his session, Dr Benjamin Ungar discussed the epidemiology of alopecia areata in the context of a broader symposium covering various aspects of the disease.
Prior to his session, Dr Benjamin Ungar discussed the epidemiology of alopecia areata in the context of a broader symposium covering various aspects of the disease.
The US FDA has approved an update to the label for Dupixent (dupilumab) for atopic dermatitis for patients ages 12 years and older with AD and uncontrolled moderate to severe involvement of the hands and/or feet.
The US FDA has approved an update to the label for Dupixent (dupilumab) for atopic dermatitis for patients ages 12 years and older with AD and uncontrolled moderate to severe involvement of the hands and/or feet.
Elucidating structure-function relationships of proteins involved in skin diseases and therapeutic agents and their targets generates new molecular insights that advance patient care.
Elucidating structure-function relationships of proteins involved in skin diseases and therapeutic agents and their targets generates new molecular insights that advance patient care.
Explore the ethical flaws in labeling alopecia areata as a cosmetic concern. Take the quiz to uncover the strongest rationale for reclassifying AA as a medical condition.
Explore the ethical flaws in labeling alopecia areata as a cosmetic concern. Take the quiz to uncover the strongest rationale for reclassifying AA as a medical condition.
Test your knowledge of how alopecia areata has been historically underrecognized in medicine. Which sociocultural or diagnostic factors contributed to its clinical minimization?
Test your knowledge of how alopecia areata has been historically underrecognized in medicine. Which sociocultural or diagnostic factors contributed to its clinical minimization?
Discover the evolutionary theory behind the emotional weight of alopecia areata. Quiz yourself on the biologic and social cues tied to hair visibility and human connection.
Discover the evolutionary theory behind the emotional weight of alopecia areata. Quiz yourself on the biologic and social cues tied to hair visibility and human connection.
When dermatitis worsens during topical calcineurin inhibitor therapy, what's your next move? Quiz yourself on clinical best practices in ACD evaluation.
When dermatitis worsens during topical calcineurin inhibitor therapy, what's your next move? Quiz yourself on clinical best practices in ACD evaluation.